3 ms·
Every mental health drug on the market was approved based on improvement in some sort of metric. Measuring improvements in lifespan or lack thereof is impractic
by nradov 3y ago
Every mental health drug on the market was approved based on improvement in some sort of metric. Measuring improvements in lifespan or lack thereof is impractical because it takes too long for any differences to become apparent in study populations. Suicide rates are also difficult to study because the baseline annual rate is very low even in mentally ill populations so that also requires large, long-term studies to see statistically significant effects.
We generally have no way to cure the root causes of mental health conditions severe enough to qualify for an official DSM5 type diagnosis. Discontinuing treatment is often not a realistic goal, although in some cases patients can learn coping strategies which reduce the need for medication or frequent talk therapy sessions.
This stuff is just fundamentally different from treating a medical condition like type-2 diabetes where there are clear biomarkers and results are often clear within months.